Clinical Trial Update: A Study of Apatinib Treatment in for Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for apatinib in advanced ovarian cancer, with unclear current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: The People's Hospital of Leshan | Conditions: Ovarian Cancer, Chemotherapeutic Toxicity | Phase 2 | Status: UNKNOWN